| Literature DB >> 33223974 |
Abdelhakim Allali1, Mohamed Abdel-Wahab2, Hussein Traboulsi1, Rayyan Hemetsberger1, Nader Mankerious1, Robert Byrne3, Volker Geist1, Mohamed El-Mawardy4, Dmitriy Sulimov2, Ralph Toelg1, Gert Richardt1.
Abstract
OBJECTIVES: To analyze the impact of different techniques of lesion preparation of severely calcified coronary bifurcation lesions.Entities:
Mesh:
Year: 2020 PMID: 33223974 PMCID: PMC7673940 DOI: 10.1155/2020/9740938
Source DB: PubMed Journal: J Interv Cardiol ISSN: 0896-4327 Impact factor: 2.279
Figure 1The study flowchart. SCB=scoring/cutting balloons; PCI=percutaneous coronary intervention; RA=rotational atherectomy.
Baseline characteristics (n = 104 patients).
| SCB ( | RA ( |
| |
|---|---|---|---|
| Age (years) | 75.0 ± 6.6 | 74.8 ± 6.5 | 0.88 |
| Males | 34 (79%) | 47 (77%) | 0.81 |
| Height (cm) | 173.9 ± 8.7 | 171.6 ± 8.9 | 0.20 |
| Weight (kg) | 83.0 ± 13.0 | 82.3 ± 16.1 | 0.83 |
| Diabetes mellitus | 9 (21%) | 21 (34%) | 0.13 |
| Hypertension | 39 (91%) | 58 (96%) | 0.38 |
| Dyslipidemia | 26 (60%) | 45 (74%) | 0.15 |
| Current smokers | 6 (13%) | 9 (15%) | 0.91 |
| Chronic renal failure | 11 (26%) | 12 (20%) | 0.50 |
| Previous MI | 17 (39%) | 10 (16%) | 0.008 |
| Previous PCI | 20 (46%) | 26 (43%) | 0.69 |
| Previous CABG | 6 (14%) | 6 (10%) | 0.52 |
| Unstable angina | 2 (5%) | 4 (7%) | 0.68 |
| Atrial fibrillation | 3 (7%) | 11 (18%) | 0.10 |
| Left main disease | 21 (49%) | 25 (41%) | 0.43 |
| Multivessel disease | 38 (88%) | 54 (88%) | 0.98 |
| LV ejection fraction (%) | 57.5 ± 10.3 | 57.9 ± 10.1 | 0.86 |
| Multilesion PCI | 22 (51%) | 29 (48%) | 0.72 |
| Unfractionated heparin | 43 (100%) | 61 (100%) | 1.00 |
| Bivalirudin | 0 (0%) | 0 (0%) | 1.00 |
| GP IIb/IIIa antagonists | 0 (0%) | 2 (3%) | 0.51 |
Values are n (%) or mean ± SD; CABG=coronary artery bypass graft, GP=glycoprotein, LV=left ventricle, MI=myocardial infarction, PCI=percutaneous coronary intervention, RA=rotational atherectomy, and SCB=scoring/cutting balloon. Glomerular filtration rate <60 ml/min.
Angiographic and procedural characteristics (n = 115 lesions).
| SCB ( | RA ( |
| |
|---|---|---|---|
|
| |||
| Location | 0.84 | ||
| Left main | 12 (25.5%) | 15 (22.1%) | |
| Left anterior descending | 28 (59.6%) | 43 (63.2%) | |
| Left circumflex | 5 (10.6%) | 8 (11.8%) | |
| Right coronary artery | 2 (4.3%) | 2 (2.9%) | |
| Reference vessel diameter (mm) | 3.27 ± 0.46 | 3.26 ± 0.45 | 0.87 |
| Lesion length (mm) | 26.06 ± 13.84 | 27.34 ± 14.83 | 0.64 |
| Diameter stenosis (%) | 83.57 ± 8.99 | 85.94 ± 9.63 | 0.19 |
| Ostial location | 15 (31.9%) | 31 (45.6%) | 0.14 |
| Angle > 70% between MB and SB | 18 (38.3%) | 23 (33.8%) | 0.62 |
| SB > 2 mm | 41 (87.2%) | 54 (79.4%) | 0.28 |
| True bifurcation lesions | 23 (49%) | 29 (43%) | 0.50 |
| Medina classification | |||
| 1.1.0 | 19 (40.4%) | 30 (44.1%) | |
| 1.1.1 | 18 (38.3) | 26 (38.2%) | |
| 1.0.1 | 2 (4.2%) | 1 (1.5%) | |
| 1.0.0 | 0 | 1 (1.5%) | |
| 0.1.1 | 2 (4.2%) | 1 (1.5%) | |
| 0.1.0 | 5 (10.6%) | 8 (11.7%) | |
| 0.0.1 | 1 (2.1%) | 1 (1.5%) | |
|
| |||
|
| |||
| SCB or RA in SB | 3 (6.3%) | 2 (2.9%) | 0.38 |
| Wire in SB | 28 (59.7%) | 36 (52.9%) | 0.48 |
| SB kissing or balloon dilation after stenting | 17 (36.2%) | 26 (38.2%) | 0.82 |
| Stenting technique | 0.75 | ||
| One-stent technique | 36 (76.6%) | 51 (75%) | |
| Two-stent technique | 10 (21.3%) | 17 (25%) | |
| Culotte | 6 (12.8%) | 6 (8.8%) | |
| T-stenting | 1 (2.1%) | 2 (2.9%) | |
| DK-crush | 0 | 1 (1.5%) | |
| Minicrush | 1 (2.1%) | 1 (1.5%) | |
| TAP stenting | 2 (4.2%) | 7 (10.3%) | |
| No stent | 1 (2.1%) | 0 | |
| Stenting of the SB | 10 (21.3%) | 17 (25%) | 0.85 |
| Elective | 7 (14.9%) | 11 (16.2%) | |
| Bailout | 3 (6.4%) | 6 (8.8%) | |
| POT | 28 (59.6%) | 42 (61.8%) | 0.81 |
| LMT involvement during the PCI | 21 (44.7%) | 28 (41.2%) | 0.71 |
| Cutting/scoring balloon diameter (mm) | 3.04 ± 0.32 | — | — |
| Cutting/scoring balloon pressure (atm) | 15.30 ± 2.3 | — | — |
| Starting burr size (mm) | — | 1.51 ± 0.17 | — |
| Max. burr size (mm) | — | 1.53 ± 0.17 | — |
| Use of >1 burr | — | 6 (8.8%) | -— |
| Rotational speed (RPM) | — | 164,895 ± 22,038 | — |
| Number of predilatation balloons | 1.74 ± 0.85 | 1.75 ± 0.98 | 0.95 |
| Max. predilatation balloon diameter (mm) | 2.78 ± 0.47 | 2.90 ± 0.38 | 0.16 |
| Max. predilatation balloon pressure (atm) | 18.22 ± 3.43 | 19.50 ± 5.08 | 0.20 |
| No. of stents/lesions | 1.85 ± 0.92 | 1.50 ± 0.68 | 0.02 |
| Total stent length/lesion (mm) | 37.09 ± 17.63 | 33.88 ± 15.71 | 0.31 |
| Min. stent diameter (mm) | 3.14 ± 0.41 | 3.08 ± 0.47 | 0.50 |
| Max. stent diameter (mm) | 3.43 ± 0.41 | 3.30 ± 0.40 | 0.09 |
| Max. stent implantation pressure (atm) | 16.61 ± 2.83 | 16.92 ± 3.32 | 0.57 |
| Balloon postdilatation | 41 (87.2%) | 62 (91.1%) | 0.50 |
| Max. postdilatation balloon diameter (mm) | 3.56 ± 0.56 | 3.65 ± 0.53 | 0.06 |
| Max. postdilatation balloon pressure (atm) | 20.54 ± 3.23 | 21.13 ± 4.10 | 0.44 |
| Procedural result on SB | |||
| Compromised at any time during the procedure | 25 (53.2%) | 28 (41.2%) | 0.20 |
| Compromised at the end of the procedure | 15 (31.9%) | 5 (7.4%) | 0.001 |
| Mechanism of SB compromise | |||
| Significant stenosis | 13 (27.7%) | 4 (5.9%) | |
| Dissection | 2 (4.3%) | 1 (1.5%) | |
| TIMI flow <3 in SB | 4 (8.5%) | 2 (3%) | |
Values are n (%) or mean ± SD; DK-crush = double kissing crush; MB = main branch; LMT = left main trunk; POT = proximal optimization technique; RPM = rotations per minute; RA = rotational atherectomy; SB = side branch; SCB = scoring/cutting balloon; TAP = T-and-protrusion technique. True bifurcation lesions: Medina 1.1.1, 1.0.1, and 0.1.1.
Procedural and in-hospital outcome (n = 104 patients).
| SCB ( | RA ( |
| |
|---|---|---|---|
| Procedural duration (min) | 77.9 ± 46.3 | 96.5 ± 36.3 | 0.02 |
| Fluoroscopy time (min) | 19.4 ± 15.2 | 26.9 ± 12.5 | 0.01 |
| Contrast amount (ml) | 234.3 ± 107.1 | 273.0 ± 116.1 | 0.08 |
| Large dissection (>5 mm) | 6 (13%) | 1 (2%) | 0.02 |
| Perforation | 2 (5%) | 2 (3%) | 1.00 |
| Pericardial effusion | 0 (0%) | 2 (3%) | 0.51 |
| No/slow flow | 0 (0%) | 2 (2%) | 0.49 |
| Final TIMI flow < III in MB | 0 (0%) | 1 (2%) | 0.41 |
| Residual stenosis > 20% in MB | 2 (5%) | 0 (0%) | 0.17 |
| Stent failure | 0 (0%) | 4 (7%) | 0.14 |
| Crossover from SCB to RA | 0 (0%) | 11 (18%) | 0.002 |
| Death | 0 (0%) | 0 (0%) | 1.00 |
| Myocardial infarction | 0 (0%) | 1 (2%) | 1.00 |
| Target vessel re-PCI | 0 (0%) | 0 (0%) | 1.00 |
| CABG | 0 (0%) | 0 (0%) | 1.00 |
| Stent thrombosis | 0 (0%) | 0 (0%) | 1.00 |
| Access site complications | 2 (5%) | 2 (3%) | 1.00 |
Values are n (%) or mean ± SD; CABG = coronary artery bypass graft; MB = main branch; PCI = percutaneous coronary intervention; RA = rotational atherectomy; SCB = scoring/cutting balloon; TIMI = thrombolysis in myocardial infarction. Stent failure occurred in patients initially randomized to an SCB strategy, and a crossover to RA was performed. The interpretation of this finding is biased by the fact that crossover patients who were initially randomized to an SCB strategy are included in the RA group.
Figure 2Evolution of median value of cardiac biomarkers in patients with (n=20) and without (n=84) compromised side branch at the end of the procedure.